BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9660541)

  • 1. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
    Schiebe ME; Hoffmann W; Belka C; Bamberg M
    Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitomycin-C induced hemolytic uremic syndrome: a case report.
    Gundappa RK; Sud K; Kohli HS; Gupta KL; Joshi K; Sakhuja V
    Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
    Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
    Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
    Shah R; Beem E; Sautina L; Zharikov SI; Segal MS
    Nephrol Dial Transplant; 2007 Feb; 22(2):617-20. PubMed ID: 17041000
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
    Catalano C; Gianesini C; Fabbian F
    Nephron; 2002 Jun; 91(2):324-6. PubMed ID: 12053072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
    El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
    Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mitomycin-induced hemolytic-uremic syndrome].
    Zeller G; Wandel E; Schwarting A
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

  • 13. Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
    Groff JA; Kozak M; Boehmer JP; Demko TM; Diamond JR
    Am J Kidney Dis; 1997 Feb; 29(2):280-4. PubMed ID: 9016902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy.
    Torra R; Poch E; Torras A; Bombí JA; Revert L
    Chemotherapy; 1993; 39(6):453-6. PubMed ID: 8222875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration.
    Nishiyama Y; Komaba Y; Kitamura H; Katayama Y
    Intern Med; 2001 Mar; 40(3):237-40. PubMed ID: 11310491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
    Kikuchi H; Kanamaru R
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
    Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
    Borghardt EJ; Kirchertz EJ; Marten I; Fenchel K
    Transfus Sci; 1998 Mar; 19 Suppl():5-7. PubMed ID: 10178695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.